{"slideshow_credits": null, "snippet": "AT&T is in talks to buy DirecTV. | Pfizer\u2019s deal for AstraZeneca raises a public policy red flag. | Allergan rejects Valeant\u2019s bid and focuses on its own strategy. | Annual meetings of Wall Street banks give shareholders a chance to air their...", "abstract": "AT&T is in talks to buy DirecTV. | Pfizer\u2019s deal for AstraZeneca raises a public policy red flag. | Allergan rejects Valeant\u2019s bid and focuses on its own strategy. | Annual meetings of Wall Street banks give shareholders a chance to air their grievances.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Sydney", "role": "reported", "lastname": "EMBER", "rank": 1, "organization": ""}], "original": "By SYDNEY EMBER"}, "web_url": "http://dealbook.nytimes.com/2014/05/13/morning-agenda-att-courts-directv/", "lead_paragraph": null, "headline": {"main": "AT&T Pursues DirecTV", "kicker": "DealBook"}, "_id": "5372069938f0d812d61f26f6", "word_count": "1952", "multimedia": [], "pub_date": "2014-05-13T07:47:16Z", "source": "The New York Times", "news_desk": "Business", "keywords": [], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}